◆
BLACKSPECTER
AI Chat öffnen →
BlackSpecter
›
Aktien
›
NVS
NVS
(NVS)
Kennzahlen
Marktkapitalisierung
n/a
KGV (TTM)
n/a
Umsatz (TTM)
n/a
EBITDA
n/a
Dividendenrendite
n/a
52W Hoch
n/a
52W Tief
n/a
Beta
n/a
EPS (TTM)
n/a
Forward KGV
n/a
PEG Ratio
n/a
Short-Quote
n/a
Analysten-Ratings
Keine Analysten-Daten verfügbar
Earnings
Keine Earnings-Daten verfügbar
Aktuelle News
GlobeNewswire
·
vor 1 Tagen
Advancements in CKD Care: How New Therapies from AstraZeneca, Johnson & Johnson, Novartis, Bayer, and Amgen Are Changing the Landscape
MT Newswires
·
vor 1 Tagen
Novartis' Vanrafia Wins Health Canada Approval for IgA Nephropathy
Business Wire
·
vor 2 Tagen
Chai Discovery Announces Collaboration with Novartis to Advance AI-Driven Antibody Discovery
The Wall Street Journal
·
vor 3 Tagen
Can AI Make Better Drugs? Not on Wall Street’s Timeline
Zacks
·
vor 4 Tagen
Reasons Why Investors Should Consider Betting on PTC Stock Now
Motley Fool
·
vor 5 Tagen
Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
Frag BlackSpecter AI über NVS
Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.
Ist NVS kaufenswert?
NVS Earnings Analyse
NVS Bewertung
AI Chat öffnen →